Insulin manufacturers advertise often, especially in major American newspapers. Most striking to me are the full-page New York Times ads Eli Lilly and Novo Nordisk have run over the years. These ads highlight the companies’ respective patient assistance programs, which have been proven unreliable for most, as a solution for those struggling to afford their insulin. The irony is that these ads are placed in a newspaper whose daily print delivery subscription is priced at $1,040 a year, an expense I doubt those who are unable to afford their insulin are able to pay.

Oh, look, another great reason to support adblockers.

You know, I used to be on the “Adblock moderate” track, but I get more vehement by the day, and can’t help but dream about how many global problems a pi-hole in every household would solve.

And rejecting ads is something actually doable by the public.